Assembly and Folding Properties of Cytosolic IgG Intrabodies

[1]  T. Boldicke Single domain antibodies for the knockdown of cytosolic and nuclear proteins. , 2017 .

[2]  T. Böldicke Single domain antibodies for the knockdown of cytosolic and nuclear proteins , 2017, Protein science : a publication of the Protein Society.

[3]  S. Dübel,et al.  Antibodies inside of a cell can change its outside: Can intrabodies provide a new therapeutic paradigm? , 2016, Computational and structural biotechnology journal.

[4]  J. Riemer,et al.  Balancing oxidative protein folding: the influences of reducing pathways on disulfide bond formation. , 2014, Biochimica et biophysica acta.

[5]  G. Vidarsson,et al.  Dynamics of Inter-heavy Chain Interactions in Human Immunoglobulin G (IgG) Subclasses Studied by Kinetic Fab Arm Exchange , 2014, The Journal of Biological Chemistry.

[6]  U. Jakob,et al.  Oxidant Sensing by Reversible Disulfide Bond Formation* , 2013, The Journal of Biological Chemistry.

[7]  M. Matsumura,et al.  The identification of free cysteine residues within antibodies and a potential role for free cysteine residues in covalent aggregation because of agitation stress. , 2013, Journal of pharmaceutical sciences.

[8]  B. Stockwell,et al.  Protein Folding Drives Disulfide Formation , 2012, Cell.

[9]  Max Tejada,et al.  Identification and characterization of buried unpaired cysteines in a recombinant monoclonal IgG1 antibody. , 2012, Analytical chemistry.

[10]  Hongcheng Liu,et al.  Disulfide bond structures of IgG molecules , 2012, mAbs.

[11]  É. Margittai,et al.  Oxidative Protein Folding in the Secretory Pathway and Redox Signaling Across Compartments and Cells , 2011, Traffic.

[12]  Douglas S Rehder,et al.  Cysteine sulfenic acid as an intermediate in disulfide bond formation and nonenzymatic protein folding. , 2010, Biochemistry.

[13]  Sun-Gu Lee,et al.  Redesigning of anti‐c‐Met single chain Fv antibody for the cytoplasmic folding and its structural analysis , 2010, Biotechnology and bioengineering.

[14]  M. Sierks,et al.  Physico-chemical determinants of soluble intrabody expression in mammalian cell cytoplasm. , 2010, Protein engineering, design & selection : PEDS.

[15]  Hongcheng Liu,et al.  Ranking the susceptibility of disulfide bonds in human IgG1 antibodies by reduction, differential alkylation, and LC-MS analysis. , 2010, Analytical chemistry.

[16]  D. Ouellette,et al.  Studies in serum support rapid formation of disulfide bond between unpaired cysteine residues in the VH domain of an immunoglobulin G1 molecule. , 2010, Analytical biochemistry.

[17]  J. Laurence,et al.  The role of thiols and disulfides on protein stability. , 2009, Current protein & peptide science.

[18]  Lesley N. Weaver,et al.  Kinesin-14 family proteins HSET/XCTK2 control spindle length by cross-linking and sliding microtubules. , 2009, Molecular biology of the cell.

[19]  Dean P. Jones,et al.  Redox compartmentalization in eukaryotic cells. , 2008, Biochimica et biophysica acta.

[20]  T. Rabbitts,et al.  Functional intracellular antibody fragments do not require invariant intra-domain disulfide bonds. , 2008, Journal of molecular biology.

[21]  M. Matsumura,et al.  Contributions of a disulfide bond to the structure, stability, and dimerization of human IgG1 antibody CH3 domain , 2007, Protein science : a publication of the Protein Society.

[22]  J. Beckwith What Lies Beyond Uranus?: Preconceptions, Ignorance, Serendipity and Suppressors in the Search for Biology's Secrets , 2007, Genetics.

[23]  N. M. Gevondyan,et al.  Four free cysteine residues found in human IgG1 of healthy donors , 2006, Biochemistry (Moscow).

[24]  Dean P. Jones,et al.  Nuclear and mitochondrial compartmentation of oxidative stress and redox signaling. , 2006, Annual review of pharmacology and toxicology.

[25]  A. Holmgren,et al.  Thiol redox control via thioredoxin and glutaredoxin systems. , 2005, Biochemical Society transactions.

[26]  A. Messer,et al.  Intrabody applications in neurological disorders: progress and future prospects. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[27]  D. Röthlisberger,et al.  Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability. , 2005, Journal of molecular biology.

[28]  M. Quondam,et al.  The intracellular antibody capture technology: towards the high-throughput selection of functional intracellular antibodies for target validation. , 2004, Methods.

[29]  Jason C. Young,et al.  Pathways of chaperone-mediated protein folding in the cytosol , 2004, Nature Reviews Molecular Cell Biology.

[30]  Ursula Jakob,et al.  Not every disulfide lasts forever: disulfide bond formation as a redox switch. , 2003, Antioxidants & redox signaling.

[31]  C. Barbas,et al.  Generation and functional characterization of intracellular antibodies interacting with the kinase domain of human EGF receptor , 2003, Oncogene.

[32]  A. Schots,et al.  Formation of Disulfide Bridges by a Single-chain Fv Antibody in the Reducing Ectopic Environment of the Plant Cytosol* , 2002, The Journal of Biological Chemistry.

[33]  Sun Park,et al.  PRODUCTION AND CHARACTERIZATION OF AN ANTI-IDIOTYPIC SINGLE CHAIN FV THAT RECOGNIZES AN ANTI-DNA ANTIBODY , 2002, Immunological investigations.

[34]  S. Schillberg,et al.  Apoplastic and cytosolic expression of full‐size antibodies and antibody fragments in Nicotiana tabacum , 1999, Transgenic Research.

[35]  P. Carter,et al.  Contribution of domain interface residues to the stability of antibody CH3 domain homodimers. , 1998, Biochemistry.

[36]  A. Plückthun,et al.  An intrinsically stable antibody scFv fragment can tolerate the loss of both disulfide bonds and fold correctly , 1998, FEBS letters.

[37]  O. Cochet,et al.  Intracellular expression of an antibody fragment-neutralizing p21 ras promotes tumor regression. , 1998, Cancer research.

[38]  A. Plückthun,et al.  Antibody scFv fragments without disulfide bonds made by molecular evolution. , 1998, Journal of molecular biology.

[39]  A. Cattaneo,et al.  Redox State of Single Chain Fv Fragments Targeted to the Endoplasmic Reticulum, Cytosol and Mitochondria , 1995, Bio/Technology.

[40]  X. Montano,et al.  Intracellular expression of the monoclonal anti-ras antibody Y13-259 blocks the transforming activity of ras oncogenes. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[41]  A. Cattaneo,et al.  Intracellular Immunization with Cytosolic Recombinant Antibodies , 1994, Bio/Technology.

[42]  A. Cattaneo,et al.  Transgenic plants expressing a functional single-chain Fv antibody are specifically protected from virus attack , 1993, Nature.

[43]  R. Glockshuber,et al.  The disulfide bonds in antibody variable domains: effects on stability, folding in vitro, and functional expression in Escherichia coli. , 1992, Biochemistry.

[44]  D. Hilvert,et al.  In vivo catalysis of a metabolically essential reaction by an antibody. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[45]  M. Neuberger,et al.  Expression and targeting of intracellular antibodies in mammalian cells. , 1990, The EMBO journal.

[46]  C. Chang,et al.  Analysis of immunoglobulin domain interactions. Evidence for a dominant role of salt bridges. , 1988, Journal of molecular biology.

[47]  J. Carlson,et al.  A new means of inducibly inactivating a cellular protein , 1988, Molecular and cellular biology.

[48]  R J Harris,et al.  Heterogeneity of recombinant antibodies: linking structure to function. , 2005, Developments in biologicals.

[49]  P. Saviranta,et al.  Selecting for antibody scFv fragments with improved stability using phage display with denaturation under reducing conditions. , 2005, Journal of immunological methods.

[50]  Wei Zhang,et al.  Free Sulfhydryl in Recombinant Monoclonal Antibodies , 2002, Biotechnology progress.

[51]  J. Schell,et al.  Self assembly of immunoglobulins in the cytoplasm of the alga Acetabularia mediterranea , 1991 .